ARTICLE | Clinical News
OMS ElectroImmunotherapy: Phase II started
August 24, 2015 7:00 AM UTC
OncoSec said the University of California San Francisco began an open-label, U.S. Phase II trial to evaluate intratumoral ImmunoPulse IL-12 given on days 1, 5 and 8 of every other 3-week cycle plus I...